Home Pilots DyAnsys’ neurostimulation device receives FDA clearance to treat post-cardiac surgery pain Pilots DyAnsys’ neurostimulation device receives FDA clearance to treat post-cardiac surgery pain By - September 27, 2022 29 0 Facebook Twitter Pinterest WhatsApp The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Babylon hires exec to manage international growth and more digital health hires Pilots - September 29, 2022 0 Abbott’s implantable cardiac monitor CardioMEMS lands expanded FDA designation Pilots - February 22, 2022 0 Q&A: Professional soccer players score telehealth partner for mental health Pilots - May 19, 2023 0 Celebrities back Function in $53M Series A funding round Pilots - June 26, 2024 0 Indian mobile health platform MFine merges with biotech company LifeCell’s diagnostic biz Pilots - July 12, 2022 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3